SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-327468
Filing Date
2015-09-24
Accepted
2015-09-24 16:30:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d169325d424b5.htm 424B5 469245
2 GRAPHIC g169325g22j31.jpg GRAPHIC 31092
3 GRAPHIC g169325g57v95.jpg GRAPHIC 41805
  Complete submission text file 0001193125-15-327468.txt   570804
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-200452 | Film No.: 151123339
SIC: 2834 Pharmaceutical Preparations